Seek urgent medical attention if night sweats occur with: Drenching sweats with high fever Chest pain or severe shortness of breath Confusion or disorientation Severe symptoms in immunocompromised individuals Contact your healthcare provider if night sweats occur with: Unexplained weight loss (beyond expected weight loss from GLP-1 therapy) Persistent fever or chills Fatigue that interferes with daily activities Enlarged lymph nodes Persistent cough Changes in bowel habits or blood in stool (if other concerning symptoms are present) For patients with diabetes, symptoms suggesting hypoglycemia during sleep episodes require prompt evaluation
Hepatic lipotropic activity returns to baseline within one injection cycle
According to a statement from the company, revenue increased 45% to $13.53 billion, driven by volume growth from Mounjaro and Zepbound. At the same time, lawsuits related to injuries caused by Mounjaro and other GLP-1 drugs also increased
Backed by years of scientific research, CarnoSyn is the only patented beta-alanine on the market
In order to limit GLP-1 costs and prioritize the cohorts most at risk, payers should develop a risk stratification rubric to segment and prioritize patients for GLP-1 weight loss coverage in cases where it is medically necessary and/or where cost of care can be lowered the most
potentially fatal disturbances of cardiac conduction (widening of QRS), arrhythmias & seizures due to Na channel block (cardiac & CNS) Pharmacokinetics: PO, metabolized in the liver (P450 - 2D6)
